A mouse model system has been developed to examine the ability of purified virus proteins to protect mice from infection with the paramyxovirus simian virus 5. The system is based on the infection of mouse lungs by intranasal administration of infectious virus. The relative amounts of virus proteins and nucleic acid present within infected lungs were estimated either by Western blot analysis of disrupted lung tissues or by in situ hybridization studies using cryostat sections of infected lungs. During a normal time course of infection in non-immunized mice increasing amounts of virus protein and nucleic acid were detected in the lungs until 3 days post-infection (p.i.). Thereafter the amount of virus present within the lungs remained relatively constant until 7 days p.i. when there was a rapid decrease. Cytotoxic T cells, but not neutralizing antibody, could be detected at the time when the amount of virus within the lungs was decreasing. Prior immunization of mice with solid matrix-antibody-antigen (SMAA) complexes containing either surface or internal virus structural proteins reduced the amount of virus replication within infected lungs, the greatest degree of protection being observed when nucleoprotein or matrix protein was used to immunize the mice. There was no correlation between the degree of protection observed and the level of neutralizing antibody present in immunized animals; no neutralizing antibody was detected in mice immunized with internal virus proteins even at the time of sacrifice 5 days p.i. We have previously shown that immunization of mice with SMAA complexes containing either surface or internal virus structural proteins can induce cytotoxic T cells and thus conclude that the most likely explanation for the protection observed in immunized mice is through the induction of cytotoxic T cells.
INTRODUCTION
Simian virus 5 (SV5) is a member of the paramyxovirus family, a group of viruses that cause a number of serious diseases in both man and animals (Pringie, 1987) . The virion of SV5 contains six structural proteins (Mountcastle et al., 1971 ; McSharry et al., 1975; Peluso et al., 1977) three of which, the nucleoprotein (NP), phosphoprotein (P) and large (L) protein, together with the single-stranded genomic RNA, make up the nucleocapsid complex. The nucleocapsid is surrounded by a lipoprotein envelope through which the haemagglutinin-neuraminidase (HN) and fusion (F) proteins protrude. The matrix (M) protein is located between the envelope and nucleocapsid. The HN and F proteins are glycosylated and act as target antigens for antibodymediated virus neutralization (Choppin & Scheid, 1980; Paterson et al., 1987) . We have previously isolated a bank of MAbs with specificities for the HN, F, NP, P and M proteins of this virus, the MAbs to HN and F proteins having the ability to neutralize virus infectivity (Randall et al., 1987) . SV5 also encodes two non-structural proteins, V and SH, polypeptide V is antigenically related to P and appears in part to be a truncated form of P (Paterson et al., 1984; Hiebert et al., 1985) .
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Previous studies have shown that SV5 replicates in mouse and hamster lungs (Chang & Hsiung, 1965) and that immunization of hamsters with vaccinia virus recombinants containing either the HN gene or F gene affords a degree of protective immunity to hamsters upon subsequent challenge with virus (Paterson et al., 1987) . This protection was assumed to be due to the induction of neutralizing antibody in immunized animals, cytotoxic T (Tc) cell activity was not measured. However, work with respiratory syncytial virus has shown that the F protein is a major target antigen for Tc cells (Pemberton et al., 1987) . Studies on influenza virus and vesicular stomatitis virus have shown that the major Tc cell response to these viruses may also be directed via Tc cell recognition of epitopes on the internal virus structural proteins (Townsend et al., 1984; Yewdell et al., 1985 Yewdell et al., , 1986 Gotch et al., 1987) . Immunization of mice with the influenza virus NP also appears to induce a Tc cell response that aids recovery from infection by this virus (Wraith et al., 1987) and influenza virus NP-specific Tc cell clones are protective in vivo (Taylor et al., 1986) . In addition, it has recently been reported that rabies virus ribonucleoprotein can induce protective immunity (Dietzschold et d., 1987) . We have shown that solid matrix-antibody-antigen (SMAA) complexes containing internal or external proteins of SV5 can induce Tc cells specific for SV5 (Randall & Young, 1988) . In this paper we examine the ability of such SMAA complexes to induce protective immunity and show that immunization with either internal or external virus structural proteins reduces the amount of virus replication in the lungs of mice upon subsequent challenge with SV5.
METHODS

Cells and viruses.
BHK and Veto cells (Flow Laboratories) were grown as monolayers in 75 cm 2 tissue culture flasks or in rotating 80 oz Winchester bottles, in Dulbecco's modification of Eagle's tissue culture medium containing 10~ newborn calf serum. A human isolate of SV5 (LN; Goswami et M., 1984) was grown and titrated under appropriate conditions in Veto cells using medium containing 2% calf serum.
Production of SMAA complexes, and immunization of mice. Staphylococcus aureus-antibody complexes were made by incubating equal volumes of ascitic fluids containing Protein A-binding MAbs (Randall et al., 1987) with 'fixed' and killed suspensions of the Cowan A strain of S. aureus (10 ~ w/v; Kessler, 1975) . Unbound antibody was removed by suspension and sedimentation (2500 g for 3 min) of these complexes three times in phosphate-buffered saline (PBS). Soluble antigen extracts were prepared from SV5-infected BHK cells as previously described (Randall et al., 1987) . These extracts were then mixed continuously with the solid matrix-antibody complexes (20 pl of a 10% w/v solid matrix-antibody complex/2 x 10 s cell equivalents of antigen extract), for 4 to 6 h at 4 °C. The resulting SMAA complexes were washed three times by sedimentation (3300 g for 3 to 10 min) from and resuspension in immune precipitation buffer (20 mM-Tris-HC1 pH 7.2, 5 mM-EDTA, 0.5 % NP40, 0.1% SDS and 0.65 M-NaC1) and twice in PBS. Mice were immunized intraperitoneally with either 2 to 5 ~tg (NP, M, HN, P) or 0.1 to 0.2 pg (F) of virus protein attached to S. aureus-antibody complexes (as 200 ~tl aliquots of 0.5% w/v suspension of the S. aureus-antibody complexes) with a gap of 3 to 4 weeks between the first and second immunizations. Ten days after the second immunization the mice were bled from the tail vein and the sera stored at -20 °C until required. Three to 4 weeks after the second immunization mice were infected with SV5.
Infection of mice with SV5. Mice, while anaesthetized with ether, were infected by inhalation of 5 × l06 to 10 x 106 p.f.u, of the LN strain of SV5 in !00/al of growth medium. At various times after infection the mice were sacrificed and the lungs removed. Lungs on which in situ hybridization was to be performed were frozen directly in liquid nitrogen and stored at -70 °C, while lungs for Western blot analysis were weighed and frozen at -70 °C, until required.
Western blot analysis o flung extracts from S V5-infected mice. Lungs were homogenized in PBS (20 % w/v), using a MSE overhead homogenizer, sonicated, added to SDS-PAGE disruption buffer and heated for 5 rain at 80 °C. Particulate material was removed by sedimentation (6000 g for 3 rain) and the dissociated polypeptides were separated by electrophoresis through a 15 % SDS-polyacrylamide mini-slab gel. The separated polypeptides were transferred to nitrocellulose using a semi-dry multiple gel electroblotter. The nitrocellulose was then react~ ~ with a pool of monoclonal antibodies (MAbs) to the P protein and bound antibody was detected by ~2SI-labelled Protein A and autoradiography in a manner previously described (Randall et al., 1987) .
In situ hybridization. Frozen mouse lungs were sectioned using a Bright OTF/AS cryostat. Sections were fixed in ethanol :acetic acid (3:1, v/v) for 15 min at room temperature, washed with absolute ethanol for 5 min and stored desiccated at -20 °C until required. Before hybridization the sections were pretreated with 0.2 M-HC1 and proteinase K to increase diffusion of the probe (Haase et al., 1984) . Radioactively labelled ssDNA probes specific for the HN gene of SV5 were prepared by primer extension and excision of the HN gene cloned in M13 (obtained originally from R. Lamb as an insert in pBR322; Paterson et aL, 1984) followed by purification of the single-stranded probe on a 2~ low melting point agarose gel (Jeffreys et al., 1985) . Hybridization conditions used for binding the ssDNA probe to the lung sections were based on those described by Haase et al. (1984) for hybridization to RNA. Radioactively labelled bound probes were detected by autoradiography using Ilford K5 photographic emulsion.
Preparation of radiolabelled antigen extracts, immune precipitation and SDS-PAGE.
The methodology for these techniques has been described elsewhere (Randall et al., 1987) . Polypeptides present in immune precipitates (Fig. 4) were separated by electrophoresis through polyacrylamide slab gels of standard size and thickness (2 mm) but the antibody-antigen polypeptides present in SMAA complexes (Fig. 3 ) and in lung extracts (Figs. 1 and 5) were separated on thin (0-4 mm) mini-slab gels using a Uniscience (London, U.K.) mini-gel system.
Generation of Tc cells. Spleen cells were pooled from groups of three mice that had been infected with SV5 for 5 days and that had been previously immunized with S. aureus-antibody or S. aureus-antibody-antigen complexes. The spleen cells.were restimulated in vitro with SV5-infected spleen ceils for 5 days in a manner described for the generation of Tc cells specific for respiratory syncytial virus (Bangham et al., 1985) . Bulk cultures were restimulated for a further 5 days with SV5-infected spleen cells and the 10 day cultures were assayed for the presence of Tc cells.
Target cells and cytotoxicity assays. Target cells were P815 mastocytoma cells that had been infected with SV5 at an m.o.i, of 0.5 to 2 p.f.u./cell for 16 to 18 h. Uninfected P815 cells were used as controls for non-specific lysis. A standard 51Cr release assay, performed in U-bottomed microtitre plates was employed based on methods described in detail elsewhere (Zweerink et al., 1977 ; Bangham et al., 1985) . Tests were set up in triplicate using 10* target cells/well. 
RESULTS
Time course o f S V 5 infection in mouse lungs
Anaesthetized mice were infected intranasally with 5 x 106 to 10 x 106 p.f.u, of SV5 and groups of three mice were sacrificed at daily intervals until 7 days post-infection (p.i.). The relative amounts o f virus protein and nucleic acid present within infected lung material was estimated either by Western blot analysis of disrupted lung tissue, using a pool of M A b s specific for the P proteins of SV5 (Fig. 1) Fig. 1 . Autoradiogram of Western blot used to detect the presence of the P protein of SV5 in lung extracts of mice infected with SV5. Mice were infected intranasally with SV5 and groups of three mice were sacrificed at 1 to 7 days p.i. (lanes 2 to 8 respectively). The polypeptides present in lung extracts were separated on a 15 ~ SDS-polyacrylamide mini-slab gel, transferred to nitrocellulose and the SV5 P protein was detected using a pool of MAbs specific for this protein. Lane 1 shows lung extracts from uninfected mice. using ssDNA probes specific for the HN gene of SV5 (Fig. 2) . These results clearly show that SV5 replicates in mouse lungs. Increasing amounts of virus protein and nucleic acid were detected until 3 days p.i., thereafter the amount of virus present within the lungs remained relatively constant until 7 days p.i. when there was a rapid decrease. procedure resulted in the virus proteins being purified to near homogeneity as judged by SDS-PAGE (Fig. 3) . Groups of three mice were immunized twice intraperitoneaUy with these S. aureus-antibody-antigen complexes. Ten days after the second immunization the mice were bled and the sera tested for the ability to precipitate SV5 proteins (Fig. 4) . Sera from mice aureus-antibody-antigen complexes containing the NP, P, M, F or HN proteins, or with S. aureusantibody complexes alone (control mice; C). The results of two independent experiments are shown (a and b); a short (1 day; top) and long (4 day; bottom) exposure of the Western blot is shown for the second experiment and an uninfected (U) sample of mice is included. Mice challenged in the first experiment (a) were the same mice whose sera were used in the immune precipitation test shown in Fig.  4 . The immune precipitation results using sera taken from the mice challenged in the second experiment (b) were similar to those shown in Fig. 4 (data not shown).
Protection of mice by immunization with internal and external virus structural proteins
• immunized with the HN, F and M proteins precipitated only the appropriate proteins. However, sera from mice immunized with N P also precipitated the P protein and from those immunized with the P protein the sera precipitated small amounts of NP. This is because N P and P protein together with the L protein form complexes and it is difficult to purify one protein from the others completely (Randall et al., 1987) . The minor protein bands present in the immune precipitates formed using anti-NP or -P sera have also been shown to be antigenically related to either the N P or P proteins and are present in immune precipitates formed using MAbs with specificities for the N P or P proteins (Randall et al., 1987) . All the sera from immunized mice were tested for their ability to neutralize virus infectivity. The anti-HN sera had high titres of neutralizing antibody (1/800 to 1/1600) while the anti-F sera had lower titres of neutralizing antibody (1/40 to 1/100). The latter result may have been in part due to the smaller amount of F antigen bound to the S. aureus-antibody complexes used (0.1 to 0.1 btg of F compared to 2 to 5 txg of HN, NP, M and P; Fig. 3 ). No neutralizing activity was measured in any of the anti-NP, P or M sera even at 1/20 dilutions of sera. Three weeks after the second immunization mice were challenged with SV5 by direct infection of their lungs. Either 4 (Fig.  5a ) or 5 days (Fig. 5b) p.i. the mice were sacrificed and the amount of virus protein in their lungs was estimated by Western blot analysis using a pool of MAbs with specificities for the P protein (Fig. 5) . These experiments showed that immunization with both external virus glycoproteins and internal structural proteins reduced the amount of virus present within the lungs compared to non-immunized mice or mice immunized with S. aureus-antibody complexes alone. In situ hybridization also showed qualitatively that there was less virus genetic information in the lungs of infected immunized mice compared to control mice; for example, compare in Fig. 2 the level of in situ hybridization observed in control lungs 4 days p.i. with that in lungs taken from a mouse that had been immunized with the HN protein before infection.
Immune response of mice after infection with SV5
The level of neutralizing antibody was measured in the sera of mice from the second challenge experiment (Fig. 5 b) at the time of sacrifice 5 days p.i. No neutralizing antibody was detected in the sera of non-immunized mice or mice immunized with the NP, P or M proteins. The level of neutralizing antibody in mice immunized with the HN protein was similar both before and after challenge with virus (1/800 to 1/1600). Thus, there was no correlation between the level of neutralizing antibody and the degree of protection observed. In a further series of experiments we therefore looked for the presence of SV5-specific Tc cells in immunized and non-immunized mice 5 days after challenge with SV5. The spleen cells were isolated, stimulated in vitro and the presence of Tc cell activity was measured by 51Cr release assays.
These results showed that SV5-specific Tc ceils could be detected in both immunized and nonimmunized mice 5 days after challenge with virus but not in uninfected mice (Fig. 6) . The highest level of Tc cell activity was present in mice immunized with the NP and M proteins. We have shown previously that SV5-specific Tc cells can be detected in mice immunized with external or internal virus structural proteins before challenge of the mice with virus (Randall & Young, 1988) .
DISCUSSION
Previous work has shown that SV5 replicates in mouse lungs with maximal titres of virus being detected between 4 and 6 days p.i. (Chang & Hsiung, 1965) . However, we wished to develop methods for estimating the relative amount of virus within infected lungs other than by the measurement of infectious virus, since in mice immunized with either the HN or F glycoproteins there were high levels of serum antibody that may have inactivated virus in situ upon extraction of lung material. We failed, in fact, to detect infectious virus 5 days p.i. in the lungs of mice that had been previously immunized with the HN protein, a time when we could detect virus proteins in the same lung extracts by Western blot analysis. Therefore, subsequently and in the protection experiments described in this paper we did not measure the amount of infectious virus present in the lungs, but estimated the relative amounts of virus replication either by Western blot analysis or by in situ hybridization. Our results on the time course of virus infection in mouse lungs, as estimated by these techniques, were similar to previously published results estimating the amount of infectious virus within infected lungs (Chang & Hsiung, 1965) .
The results on the induction of protective immunity clearly showed that immunization with internal and external virus structural proteins reduced the amount of virus replication within infected lungs. Furthermore, there was no correlation between the degree of protection observed and the level of neutralizing activity in the sera of immunized mice. Immunization with the NP and M proteins appeared to be particularly effective in inducing a protective immune response but neutralizing antibody was not detected in these animals even at the time of sacrifice. Although the mechanism of protection by immunization with internal proteins is not determined, it is likely that it is mediated via a Tc cell response. This would be consistent with the progress of the disease in non-immunized animals in which there is a decrease in the amount of virus within the lungs at a time when Tc cells, but not neutralizing antibody, can be detected. Furthermore, in the previous paper (Randall & Young, 1988) we showed that immunization of mice with SMAA complexes induced Tc cells specific for SV5 and that internal and external virus proteins can act as target antigens for Tc cells. It is pertinent to note that Tc cells have also been shown to play a major role in clearing other respiratory viruses, e.g. influenza virus and respiratory syncytial virus, from infected mouse lungs (Wells et al., 1983; Taylor et al., 1986 Taylor et al., , 1985 Cannon et al., 1987; Lightman et al., 1987) .
The animal model systems in which lungs are directly infected with high titre virus inocula are somewhat artificial as in a natural infection individuals would not be infected in such a manner. Thus, it is not surprising that even in immunized mice with high levels of neutralizing antibody there is a fairly high degree of virus replication as the method of infection means that there would probably be insufficient time for sufficient virus neutralization to occur to affect the number of lung cells initially infected with virus. Also, while mice immunized with the HN and F proteins had serum neutralizing antibody there may not have been any secretory antibody. Thus, even in mice immunized with either the HN or F proteins it may have been Tc cells directed against these antigens, rather than neutralizing antibody, that were responsible for the protection observed. Transfer of antibodies and primed T cells to immunodeficient mice should help in further evaluating the role of both humoral antibody and cell-mediated immune responses in clearing SV5 from infected mouse lungs.
Prior immunization with all of the virus proteins enhanced virus clearance from infected lungs. Presumably the ability of virus proteins to induce Tc cells will be dependent both on how the proteins are denatured and processed within antigen-presenting cells and virus-infected cells, and on whether the resulting peptides can bind to major histocompatibility complex (MHC) antigens (Babbit et al., 1985; Buss et al., 1986; McMichael et al., 1986; Gotch et al., 1987) . Consequently, depending on the MHC haplotype, the major antigenic determinants for inducing Tc cells may reside in different virus proteins and even in different epitopes on the same protein from one individual to another and from one animal species to another. Furthermore, the major target peptides for Tc cells may reside on different virus proteins between related viruses. For these reasons, when designing subunit vaccines against viruses where the induction of cell-mediated immunity is important in inducing protective immunity, it may be necessary to include multiple virus proteins in the vaccine in order to immunize successfully the majority of individuals. In addition, proteins rather than peptides are likely to be more useful in inducing T cell responses. When presented with a protein in an appropriate manner an individual would be able to process the protein and select the appropriate peptide for the activation of T cells on the basis of the reaction of the peptide with the MHC antigens. If peptides were to be incorporated into vaccines it might be necessary to include a large number of different peptides to bind to all the different MHC haplotypes. Furthermore, to produce successful vaccines for some viruses it may be necessary to induce both neutralizing antibody and cell-mediated immunity and consequently multiple virus proteins will need to be incorporated into the vaccine. We have shown that antigens presented in SMAA complexes can induce both humoral and Tc memory cells, that multiple virus proteins can be easily and readily incorporated into them (Randall & Young, 1988) and that immunization with such complexes can induce a protective immune response. We therefore suggest that presentation of virus proteins in SMAA complexes may be an appropriate way of producing multivalent subunit vaccines.
